Lisa Earnhardt

President & CEO
Intersect ENT

Lisa Earnhardt is President and CEO of Intersect ENT (formerly Sinexus) an early stage medical device start-up in the ear, nose and throat arena funded by premier venture capital firms Kleiner, Perkins, Caufield & Byers, US Venture Partners and PTV Sciences.

Prior to joining Intersect, Lisa was the President of Boston Scientific's Cardiac Surgery division. She played an instrumental role in the sale of that business to the Getinge Group in January 2008. Previously, Lisa held a variety of sales and marketing positions of increasing responsibility within Guidant's Cardiac Rhythm Management and Cardiac Surgery divisions, including CRM Marketing Manager-Tachyarrhythmias, CRM Regional Manager, CS National Sales Director, CS Director of Marketing and CS Vice President of Sales and Marketing.

Lisa began her career at APM/CSC Healthcare in San Francisco where she provided strategic and operational consulting services to healthcare provider organizations. She holds a M.B.A. from Northwestern's Kellogg School of Management and a B.S. in Industrial Engineering from Stanford University. Lisa serves on the boards of Intersect ENT, Nerites Corporation and the Kellogg Alumni Council.